Cargando…
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
Obesity is among the leading causes of morbidity and mortality worldwide and its prevalence continues to increase globally. Because obesity is a chronic, complex, and heterogeneous disease influenced by genetic, developmental, biological, and environmental factors, it is necessary to approach obesit...
Autores principales: | Son, Jang Won, Kim, Sungrae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801751/ https://www.ncbi.nlm.nih.gov/pubmed/33389955 http://dx.doi.org/10.4093/dmj.2020.0258 |
Ejemplares similares
-
Wegener's granulomatosis: current and upcoming therapies
por: Langford, Carol A
Publicado: (2003) -
Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies
por: Son, Jang Won, et al.
Publicado: (2015) -
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
por: Khanna, Saira, et al.
Publicado: (2019) -
An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015) -
Ankle and Foot Arthroplasty and Prosthesis: A Review on the Current and Upcoming State of Designs and Manufacturing
por: Gupta, Richa, et al.
Publicado: (2023)